Insider trade

Tyra Biosciences (TYRA)Director sold ~$113K

Nina S Kjellson, Director at Tyra Biosciences, sold ~$113K of Tyra Biosciences shares.

~$113K
Approx. value · 6,944 sh @ $16.29
3.72M
Holds after · shares reported
Traded
Jan 16, 2025
Filed
Jan 21, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 25, 2024Insider · 1 personInsiders: 2 sales (~$89K)
  2. Jan 16, 2025 · this disclosureInsiderDirector sold ~$113K of TYRA shares in the open market

What came next

  1. Jan 16, 2025InsiderDirector sold ~$14K of TYRA shares in the open market
  2. Jan 17, 2025Insider · 1 personInsiders: 2 sales (~$218K)
  3. Jan 21, 2025InsiderDirector sold ~$65K of TYRA shares in the open market
  4. Jan 23, 2025InsiderDirector sold ~$78K of TYRA shares in the open market
  5. Feb 5, 2025Insider · 1 personInsiders: 2 sales (~$74K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tyra Biosciences

For Tyra Biosciences, OQRO holds 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TYRA page.

Other recent filings by Nina S Kjellson, Director

The full history of Nina S Kjellson, Director is on the profile page.

How this filing works

Other disclosures at Tyra Biosciences

Everything OQRO holds on this company is on its TYRA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data